about
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune DysregulationInhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 ReceptorLoss of balance in normal GPCR-mediated cell trafficking
P50
Q39133276-D09C8115-87AB-45E1-877C-1B57CBA15E59Q39327528-B800B110-1326-49BB-92CF-A240EE25927DQ52806995-528BA470-498F-4901-945A-C5256119993BQ55025711-204E92A2-D8EB-4D96-A9C3-2ED27C2A643AQ92072033-43ED9FAD-8F16-4230-AD3C-B1DE328A1782Q93154608-8B50B3C0-B610-437B-8E0A-14E8C9A6CDF6Q93368908-B71BC0D3-8E74-4ED5-8475-3FB24D5215C9
P50
description
researcher (ORCID 0000-0002-3183-6236)
@en
wetenschapper
@nl
name
Otavio Cabral-Marques
@en
Otavio Cabral-Marques
@nl
type
label
Otavio Cabral-Marques
@en
Otavio Cabral-Marques
@nl
prefLabel
Otavio Cabral-Marques
@en
Otavio Cabral-Marques
@nl
P31
P496
0000-0002-3183-6236